Diabetes & Monitoring Supplies Billing

Our Diabetes & Monitoring Supplies Billing Services Cover All Your Needs

BLOOD GLUCOSE MONITOR CODING & BILLING
CGM SYSTEM CLAIM SUBMISSION
INSULIN PUMP & SUPPLY BILLING
REFILL COMPLIANCE & ELIGIBILITY TRACKING
PRIOR AUTHORIZATION MANAGEMENT
DIABETIC SHOE PROGRAM BILLING
MEDICAL NECESSITY DOCUMENTATION
DENIAL MANAGEMENT & APPEALS

What Our Diabetes & Monitoring Supplies Billing Services Cover

Diabetes and monitoring supplies billing carries a level of compliance complexity that catches most general billing teams off guard. At Unify Healthcare Services, we manage diabetes and monitoring supplies billing across the full product range - from standard blood glucose monitors and test strips to advanced CGM systems, insulin pumps, diabetic footwear, and all related supplies.

Our team understands the A-code and E-code frameworks that govern diabetes DME billing, the LCD requirements that determine CGM coverage eligibility, and the refill management discipline that keeps monthly supply accounts running without interruption. We handle everything from eligibility verification and prior authorization through clean claim submission, denial resolution, and ongoing refill billing management.

Our Diabetes & Monitoring Supplies Billing Services: Built for Accuracy

Diabetes and monitoring supplies billing operates on rules that change more frequently than most DME categories and staying current on those changes is not optional. Blood glucose monitor claims are billed under A4253 for test strips, with quantity limitations enforced per payer based on the patient's insulin regimen and testing frequency documented in the physician's order. Lancet billing under A4259 follows the same frequency-based quantity rules and must align with the strip quantities submitted on the same claim. CGM system billing under K0553 and K0554 requires a treating physician's order confirming the patient is either intensively managed with insulin or meets the alternative coverage criteria introduced under expanded Medicare CGM policy. Insulin pump billing under E0784 requires documentation of Type 1 diabetes or a qualifying Type 2 diagnosis with documented failure of multiple daily injection therapy. We manage every code, every quantity calculation, and every documentation requirement, and we track refill eligibility dates across your entire diabetes supply portfolio so not a single billing cycle is missed.

Get in Touch

Diabetes & Monitoring Supplies Billing Services for CGM and Insulin Pump Accounts

Diabetes and monitoring supplies billing services for CGM and insulin pump patients require a documentation standard that goes well beyond standard supply billing. CGM coverage under Medicare expanded significantly in recent years, but the documentation requirements that support those claims became more detailed at the same time.

Unify Healthcare Services manages CGM billing with a structured intake checklist that confirms the treating physician's order captures the required clinical indicators, the patient's insulin management regimen, and any applicable face-to-face visit documentation supporting the prescribing decision.

Prior authorization for insulin pumps varies significantly between Medicare and commercial payers, we manage those submission and tracking workflows as a standard part of every insulin pump billing account we take on.

Customers can expect

59%

Cost to Collect Reduced by

30%

Client Revenue Increased by

500+

Happy Client

98%

Collection Rate

Diabetes & Monitoring Supplies Billing: Refill Management and Quantity Compliance

Diabetes and monitoring supplies billing services for ongoing supply accounts demand strict refill compliance management. Medicare and most commercial payers enforce quantity limitations on test strips, lancets, CGM sensors, and insulin pump supplies, and billing above those limits without documented clinical justification is one of the fastest ways to trigger a post-payment audit.

Unify RCM manages refill eligibility for every diabetes supply account using payer-specific quantity tables and physician order documentation. We confirm that the treating physician's order specifies testing frequency for glucose monitor accounts and sensor replacement schedules for CGM accounts before any refill claim is submitted. For insulin pump supply billing, we track reservoir, tubing, and infusion set quantities against the payer-approved order frequency.

How we raise the bar

Refill Compliance Tracking

We manage refill eligibility dates, quantity limitations, and physician order currency for every diabetes supply account.

CGM and Insulin Pump Documentation

We review treating physician documentation, insulin regimen records, and prior authorization status before a single claim is coded.

Quantity Limitation Management

We maintain payer-specific quantity tables for every product category and apply them to every refill submission.

Diabetes Billing Compliance

Diabetes billing for long-term supply patients involves a level of ongoing documentation management that most DME billing teams underestimate. Physician orders expire. Testing frequency changes. Insulin regimens are adjusted. Each of those clinical changes has a direct impact on what can be billed, at what quantity, and under which code, and failing to update the billing record when the clinical picture changes create compliance exposure that compounds with every subsequent refill submission.

Unify RCM maintains active documentation calendars for every diabetes billing account. Treating physician orders are tracked for expiration and renewed before they lapse. When a patient's testing frequency changes, we update the quantity calculation on the next refill claim and document the clinical reason for the change. Every account stays current and every claim we submit reflects the actual clinical situation of the patient behind it.

Common Diabetes & Monitoring Supplies Billing Challenges We Solve

Diabetes DME billing generates denial patterns that repeat themselves across suppliers because the compliance rules are detailed, the quantity limits are strict, and payer policies in this category update more often than most. Below are the specific challenges we resolve for diabetes supply billing accounts every day.

Test strip and lancet quantities billed above payer-approved limits without documented clinical justification

CGM claims denied due to missing or insufficient treating physician order documentation
Insulin pump prior authorization absent or expired at the time of claim submission
Refill claims submitted before the payer-defined eligibility window opened
Treating physician order expired at the time of the refill claim submission
Delivery confirmation absent from the patient file on monthly supply claims
Diabetic shoe plan of care expired or not certified by the treating physician before billing

How We Help Providers?

Our mission is to take the refill complexity, quantity compliance burden, and documentation management out of diabetes DME billing, so your business gets paid accurately and on time.

1. Eliminate Errors Before They Reach the Payer

We apply payer-specific quantity limits and refill eligibility rules to every diabetes supply claim before submission.
2. Build Documentation That Holds Up

We review treating physician orders, insulin regimen documentation, and prior authorization status for every CGM and pump account.
3. Recover Revenue Trapped in Claims

Our billing audit identifies expired physician orders, quantity overruns, and missing delivery confirmations across your diabetes account portfolio.

Frequently Asked Questions About Diabetes & Monitoring Supplies Billing

1. What codes are used for blood glucose monitor and test strip billing?

Blood glucose monitors are billed under E2100 or E2101 depending on whether the device has voice synthesizer capability. Test strips are billed under A4253 for most standard monitors. Lancets are billed under A4259. Quantity limitations apply to both strips and lancets based on the patient's documented testing frequency and insulin regimen. The treating physician's order must specify daily testing frequency, and the quantities billed must align with that frequency, payers cross-reference the two consistently.

2. What documentation is required for CGM billing under Medicare?

Medicare coverage for CGM systems requires a treating physician's order that documents the patient's diabetes diagnosis, their current insulin therapy regimen, and the clinical rationale for continuous glucose monitoring. Under the expanded CGM coverage policy, patients who are intensively managed with insulin or who meet alternative clinical criteria may qualify. The order must be current, signed by the treating physician, and specific enough to support the CGM system and supply codes being billed. A generic prescription without qualifying clinical language is not sufficient for coverage.

3. How does refill eligibility work for diabetes supply billing?

Most payers define specific refill eligibility windows for diabetes supplies, typically allowing resupply billing after a defined percentage of the previously billed quantity has been used. For test strips and lancets, this is usually after approximately 75–85 percent of the supply period has elapsed. For CGM sensors and insulin pump supplies, manufacturer-defined replacement intervals interact with payer coverage windows. Submitting a refill claim before the eligibility window opens results in immediate denial and repeated early submissions create an audit flag that payers track across your account history.

4. What is required to bill for insulin pumps under Medicare?

Insulin pump billing under E0784 requires documentation of a diabetes diagnosis, evidence that the patient has been on multiple daily injections of insulin, and clinical documentation demonstrating that standard injection therapy has not achieved adequate glycemic control. The treating physician's order must be detailed and specific. Prior authorization is required for Medicare insulin pump claims, and the authorization must be obtained before the pump is delivered and the claim is submitted. There is no retroactive authorization pathway for insulin pumps under Medicare.

5. How do you manage quantity limits for CGM sensors and transmitters?

CGM sensors and transmitters are billed with specific quantity limitations based on the approved replacement schedule for the prescribed device. Sensors are typically replaced every 7, 10, or 14 days depending on the CGM system, and quantities must reflect that schedule. We maintain a product-specific quantity schedule for every CGM system we bill and apply payer-specific coverage rules on top of manufacturer replacement intervals for every refill submission.

6. Can you manage diabetic shoe billing alongside CGM and glucose monitor accounts?

Yes. Diabetic shoe and insert billing under the Medicare therapeutic footwear benefit is part of our standard diabetes billing workflow. The treating physician must certify the patient's diabetes diagnosis and qualifying foot condition, and the plan of care must be current at the time of billing. Annual quantity limits apply to shoes and inserts, and we track those limits alongside the patient's plan of care renewal date so billing runs on schedule and within coverage parameters every year.

Expert Diabetes & Monitoring Supplies Billing Services That Protect Your Revenue

Contact Us